Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Neuro-Oncology Advances|January 7, 2021
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modelingMarijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
The Lancet. Oncology|February 1, 2023
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working groupClaire Piccinin, Ethan Basch, Vishal Bhatnagar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 23, 2022
A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaireCecilie Delphin Amdal, Ragnhild Sørum Falk, Susanne Singer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2015
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trialLinda Dirven, Martin J van den Bent, Andrew Bottomley, et al.
The Lancet. Oncology|March 28, 2020
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field studyMichael Koller, Omar Shamieh, Marianne J Hjermstad, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
The Lancet. Oncology|June 3, 2023
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and proceduresMadeline Pe, Ahu Alanya, Ragnhild Sorum Falk, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
JAMA|February 8, 2018
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO ExtensionMelanie Calvert, Derek Kyte, Rebecca Mercieca-Bebber, et al.
Pageof 19